STEARIC ACID

SMILES

Mwt.	LogP	HBD	HBA	PSA	RB	CSP3
283.0	5.0	0	2	40.0	16	0.94

CAS

57114

UNII

4ELV7Z65AP

SYNONYMS

ZINC ID(s)

Availability

Present in 82 ZINC catalogs

This compound has been observed to have activity at 10μM or less against the following gene(s).

Name	Description	Classification
PPARD	Peroxisome proliferator-activated receptor delta	Unclassified / Unclassified
PPARA	Peroxisome proliferator-activated receptor alpha	Transcription Factor / Nr

This compound has not been in (or located in) any clinical trials (per clinicaltrials.gov).

Browse on ZINC

Misc - Miscellaneous

Gras - Generally recognized as safe.

Route	Formulation	Per Unit Dose
Buccal	Tablet	5MG
Buccal/sublingual	Tablet	6MG
Implantation	Pellet	0.2MG
Oral	Capsule	52MG
Oral	Capsule, Coated, Soft Gelatin	3MG
Oral	Capsule, Delayed Action	3MG
Oral	Capsule, Extended Release	3.23MG
Oral	Capsule, Hard Gelatin	15MG
Oral	Capsule, Sustained Action	21MG
Oral	Powder, For Suspension	24.06%
Oral	Syrup
Oral	Tablet	72MG
Oral	Tablet (Immed./comp. Release), Coated	5.3MG
Oral	Tablet (Immed./comp. Release), Uncoated, Chewable	15MG
Oral	Tablet, Coated	42.4MG
Oral	Tablet, Controlled Release	1.6MG
Oral	Tablet, Delayed Action	15MG
Oral	Tablet, Delayed Action, Enteric Coated	16MG
Oral	Tablet, Enteric Coated Particles	5MG
Oral	Tablet, Extended Release	180MG
Oral	Tablet, Orally Disintegrating	0.47MG
Oral	Tablet, Sugar Coated	0.9MG
Oral	Tablet, Sustained Action	187.5MG
Oral	Tablet, Sustained Release, Film Coated	9MG
Oral-21	Tablet	1MG
Oral-28	Tablet	1MG
Subcutaneous	Implant	1.04MG
Sublingual	Tablet	5.05MG
Topical	Cream, Augmented	3%
Topical	Cream, Emulsion, Sustained Release	16%
Topical	Emulsion, Aerosol Foam	8%
Topical	Emulsion, Cream	22.5%
Topical	Lotion	3.5%
Topical	Ointment	15%
Topical	Solution
Topical	Suspension	1.75%
Vaginal	Emulsion, Aerosol Foam	4%
Vaginal	Emulsion, Cream	14%
Vaginal	Tablet	60MG

Data provided by OpenFDA